Clinical, immunological and metabolic features and gut-brain axis markers in children with autism spectrum disorder and TORCH-associated central nervous system involvement.
In this cohort, ASD with clinical evidence of TORCH-associated central nervous system involvement was associated with greater clinical severity and higher serum inflammatory, metabolic, neuronal-injury, fecal-zonulin, and structural MRI measures than ASD without such evidence.